Pēdējā atjaunošana :
19/11/2024
vēzis narkotiku   Thiotepa  
Injekcija
Šķīduma stabilitāte Maisījuma stabilitāte Stabilitāti ietekmējoši faktori Saderība Levadīšanas veids Literatūras saraksts pdf
   Ķīmiskā uzbūve   

Oriģinālais nosaukums   Oriģinālais nosaukums     

Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām

Bedford Jaunzēlande
Ledertepa Holande
Oncotiotepa Spānija
Thioplex Itālija
Thiotepa Amerikas Savienotās Valstis, Austrālija, Austrija, Īrija, Lielbritānija, Vācija, Zviedrija
Literatūras saraksts   Injekcija   Literatūras saraksts : Thiotepa  
tips publicēšana
3 Žurnāls Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81 Žurnāls Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84 Žurnāls Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99 Žurnāls Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
169 Žurnāls Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182 Žurnāls Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
244 Žurnāls Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
249 Žurnāls Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
302 Žurnāls Murray KM, Erkkila D, Gombotz WR, Pankey S.
Stability of thiotepa (lyophilized) in 0.9% sodium chloride injection.
Am J Health-Syst Pharm 1997 ; 54: 2588-2591.
307 Žurnāls Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
905 Žurnāls Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
1410 Žurnāls Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423 Žurnāls Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
3603 Laboratorija Thiotepa (Tepadina®) - Summary of Product Characteristics
Adienne Pharma Biotech 2011
4677 plakāts Linxweiler H, Thiesen J, Krämer I.
Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags.
EAHP Congress Vienna 2022
4748 Žurnāls Linxweiler H, Thiesen J, Krämer I.
Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment.
Pharmaceutics 2023 ,15, 309.

  Mentions Légales